nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Afghan health at risk as foreign troops withdraw
|
Cousins, Sophie |
|
|
398 |
10296 |
p. 197-198 |
artikel |
2 |
Arterial hypertension
|
Brouwers, Sofie |
|
|
398 |
10296 |
p. 249-261 |
artikel |
3 |
Autoimmune pulmonary alveolar proteinosis: a discrepancy between symptoms and CT findings
|
Hawkins, Padraig |
|
|
398 |
10296 |
p. e7 |
artikel |
4 |
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
|
Wall, Emma C |
|
|
398 |
10296 |
p. 207-209 |
artikel |
5 |
Binita Kane: sharing hidden histories in heritage and health
|
Prasad, Aarathi |
|
|
398 |
10296 |
p. 201 |
artikel |
6 |
BMI and diabetes risk in low-income and middle-income countries
|
Choukem, Siméon Pierre |
|
|
398 |
10296 |
p. 190-192 |
artikel |
7 |
Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults
|
Teufel, Felix |
|
|
398 |
10296 |
p. 238-248 |
artikel |
8 |
Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19
|
Chan, Emily Ying Yang |
|
|
398 |
10296 |
p. 194-196 |
artikel |
9 |
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
|
Drake, Thomas M |
|
|
398 |
10296 |
p. 223-237 |
artikel |
10 |
CoronaVac: more data for regulators and policy makers
|
Ramasamy, Maheshi N |
|
|
398 |
10296 |
p. 186-188 |
artikel |
11 |
COVID-19: counting migrants in
|
Hargreaves, Sally |
|
|
398 |
10296 |
p. 211-212 |
artikel |
12 |
COVID-19 in Africa: a lesson in solidarity
|
The Lancet, |
|
|
398 |
10296 |
p. 185 |
artikel |
13 |
Department of Error
|
|
|
|
398 |
10296 |
p. 212 |
artikel |
14 |
Department of Error
|
|
|
|
398 |
10296 |
p. 212 |
artikel |
15 |
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
|
Tanriover, Mine Durusu |
|
|
398 |
10296 |
p. 213-222 |
artikel |
16 |
In-hospital complications associated with COVID-19
|
Gu, Xiaoying |
|
|
398 |
10296 |
p. 188-190 |
artikel |
17 |
Medicine and the monsoon
|
Amrith, Sunil |
|
|
398 |
10296 |
p. 204-205 |
artikel |
18 |
More social discontent than pandemic-related risk perception in Colombia
|
Idrovo, Alvaro J |
|
|
398 |
10296 |
p. 211 |
artikel |
19 |
Science, not speculation, is essential to determine how SARS-CoV-2 reached humans
|
Calisher, Charles H |
|
|
398 |
10296 |
p. 209-211 |
artikel |
20 |
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
|
Brown, Emily |
|
|
398 |
10296 |
p. 262-276 |
artikel |
21 |
Smarajit Jana
|
Green, Andrew |
|
|
398 |
10296 |
p. 206 |
artikel |
22 |
The final frontier: health in space
|
Burki, Talha |
|
|
398 |
10296 |
p. 199-200 |
artikel |
23 |
The Great Gatsby and the challenge of unreliable narrators
|
McCarthy, Matthew W |
|
|
398 |
10296 |
p. 203 |
artikel |
24 |
The WHO global strategy for oral health: an opportunity for bold action
|
Benzian, Habib |
|
|
398 |
10296 |
p. 192-194 |
artikel |
25 |
When art mirrors planetary health
|
Lucas, Tamara |
|
|
398 |
10296 |
p. 202 |
artikel |